Previous studies demonstrated that human serum albumin treatment had neuroprotective effects on focal and global cerebral ischemia [18, 19], subarachnoid hemorrhage [20, 21], and ICH [22]. The gene discussed is ALB; the disease is Cerebral ischemia.